158 related articles for article (PubMed ID: 37072664)
1. DEX-Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T-Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy.
Jia R; Sun T; Zhao X; Li G; Xia Y; Zhou Y; Li W; Li W; Ma D; Ye J; Ji M; Ji C
Adv Sci (Weinh); 2023 Jul; 10(19):e2205854. PubMed ID: 37072664
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles derived from T-cell acute lymphoblastic leukemia inhibit osteogenic differentiation of bone marrow mesenchymal stem cells via miR-34a-5p.
Yuan T; Shi C; Xu W; Yang HL; Xia B; Tian C
Endocr J; 2021 Oct; 68(10):1197-1208. PubMed ID: 34039781
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation.
Li J; Zhang N; Huang X; Xu J; Fernandes JC; Dai K; Zhang X
Cell Death Dis; 2013 Oct; 4(10):e832. PubMed ID: 24091675
[TBL] [Abstract][Full Text] [Related]
4. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
[TBL] [Abstract][Full Text] [Related]
5. Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy.
Jia X; Liao N; Yao Y; Guo X; Chen K; Shi P
Cancer Biol Ther; 2024 Dec; 25(1):2323765. PubMed ID: 38465622
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CDC20 promotes adipogenesis of bone marrow-derived stem cells by modulating β-catenin.
Du Y; Liu Y; Zhou Y; Zhang P
Stem Cell Res Ther; 2022 Sep; 13(1):443. PubMed ID: 36056439
[TBL] [Abstract][Full Text] [Related]
7. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
8. HIF-1A and C/EBPs transcriptionally regulate adipogenic differentiation of bone marrow-derived MSCs in hypoxia.
Jiang C; Sun J; Dai Y; Cao P; Zhang L; Peng S; Zhou Y; Li G; Tang J; Xiang J
Stem Cell Res Ther; 2015 Mar; 6(1):21. PubMed ID: 25889814
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
[TBL] [Abstract][Full Text] [Related]
10. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
[No Abstract] [Full Text] [Related]
11. The effect of electromagnetic fields on the proliferation and the osteogenic or adipogenic differentiation of mesenchymal stem cells modulated by dexamethasone.
Song M; Zhao D; Wei S; Liu C; Liu Y; Wang B; Zhao W; Yang K; Yang Y; Wu H
Bioelectromagnetics; 2014 Oct; 35(7):479-90. PubMed ID: 25145543
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy.
Tembhare PR; Sriram H; Khanka T; Chatterjee G; Panda D; Ghogale S; Badrinath Y; Deshpande N; Patkar NV; Narula G; Bagal B; Jain H; Sengar M; Khattry N; Banavali S; Gujral S; Subramanian PG
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439800
[TBL] [Abstract][Full Text] [Related]
13. B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow.
Barz MJ; Behrmann L; Capron D; Zuchtriegel G; Steffen FD; Kunz L; Zhang Y; Vermeerbergen IJ; Marovca B; Kirschmann M; Zech A; Nombela-Arrieta C; Ziegler U; Schroeder T; Bornhauser B; Bourquin JP
Haematologica; 2023 May; 108(5):1244-1258. PubMed ID: 36325888
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
[TBL] [Abstract][Full Text] [Related]
15. Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.
Xi M; Guo S; Bayin C; Peng L; Chuffart F; Bourova-Flin E; Rousseaux S; Khochbin S; Mi JQ; Wang J
Front Med; 2022 Jun; 16(3):442-458. PubMed ID: 34669156
[TBL] [Abstract][Full Text] [Related]
16. DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.
Zhou Y; Guan L; Li W; Jia R; Jia L; Zhang Y; Wen X; Meng S; Ma D; Zhang N; Ji M; Liu Y; Ji C
Cancer Lett; 2022 May; 533():215608. PubMed ID: 35240234
[TBL] [Abstract][Full Text] [Related]
17. Bmi1 Suppresses Adipogenesis in the Hematopoietic Stem Cell Niche.
Hu T; Kitano A; Luu V; Dawson B; Hoegenauer KA; Lee BH; Nakada D
Stem Cell Reports; 2019 Sep; 13(3):545-558. PubMed ID: 31257132
[TBL] [Abstract][Full Text] [Related]
18. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.
Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y
J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated systemic lymphocytes affect the balance of osteogenic/adipogenic differentiation of bone mesenchymal stem cells after local irradiation.
Xu X; Li R; Zhou Y; Zou Q; Ding Q; Wang J; Jin W; Hua G; Gao J
Stem Cell Res Ther; 2017 Mar; 8(1):71. PubMed ID: 28320453
[TBL] [Abstract][Full Text] [Related]
20. TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.
Chu M; Yin K; Dong Y; Wang P; Xue Y; Zhou P; Wang Y; Wang Y
Oncotarget; 2017 Jan; 8(1):1405-1415. PubMed ID: 27902457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
